Your browser doesn't support javascript.
loading
NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages.
Yuan, Dongchen; Hu, Jing; Ju, Xiaoman; Putz, Eva Maria; Zheng, Simin; Koda, Stephane; Sun, Guowei; Deng, Xiaoran; Xu, Zhipeng; Nie, Wei; Zhao, Yang; Li, Xianyang; Dougall, William C; Shao, Simin; Chen, Yan; Tang, Renxian; Zheng, Kuiyang; Yan, Juming.
Afiliação
  • Yuan D; Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Hu J; Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Ju X; Department of Genetics, Xuzhou Engineering Research Center of Medical Genetics and Transformation, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Putz EM; Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Zheng S; St. Anna Children's Cancer Research Institute, Medical University of Vienna, Vienna 1210, Austria.
  • Koda S; Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Sun G; Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Deng X; Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Xu Z; Jiangsu Province Key Laboratory in Anesthesiology, School of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Nie W; Department of Pathogen Biology, Jiangsu Province Key Laboratory of Modern Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
  • Zhao Y; Department of Pulmonary Medicine, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, China.
  • Li X; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
  • Dougall WC; Department of Biochemistry and Molecular Biology, School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
  • Shao S; Department of Research and Development, OriCell Therapeutics Co. Ltd, Shanghai 200131, China.
  • Chen Y; Translational Oncology Discovery Group, QIMR Berghofer Medical Research Institute, Brisbane 4702, Australia.
  • Tang R; Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Zheng K; Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • Yan J; Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
Proc Natl Acad Sci U S A ; 120(47): e2302126120, 2023 Nov 21.
Article em En | MEDLINE | ID: mdl-37967215

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2023 Tipo de documento: Article